Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | No | No |
| Is asset turnover increasing? | No | No |
| Is equity multiplier increasing? | No | Yes |
| Competitors Used |
|---|
| Azenta, Inc. |
| Bio-Rad Laboratories, Inc. |
| Personalis, Inc. |
| Waters Corporation |
| Telesis Bio, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| AZTA | BIO.B | PSNL | WAT | TBIO | ILU | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -9% | -28% | -51% | 41% | NM | -24% | ||
| Fiscal Year - 1 | 0% | -7% | -62% | 78% | -71% | -19% | ||
| Fiscal Year - 2 | 0% | -31% | -43% | 162% | -119% | -51% | ||
| Fiscal Year - 3 | -2% | 36% | -26% | 231% | 109% | 10% | ||
| Fiscal Year - 4 | -2% | 49% | -27% | NM | 133% | 14% | ||
| Fiscal Year - 5 | -7% | 36% | -16612% | 88% | NA | 24% | ||
| Average | -3% | 9% | -2804% | 120% | 13% | -8% | ||
| Median | -2% | 15% | -47% | 88% | 19% | -4% | ||
| Benchmarks | Ticker | |||||||
| Azenta, Inc. | NasdaqGS:AZTA | |||||||
| Bio-Rad Laboratories, Inc. | NYSE:BIO.B | |||||||
| Personalis, Inc. | NasdaqGM:PSNL | |||||||
| Waters Corporation | NYSE:WAT | |||||||
| Telesis Bio, Inc. | OTCPK:TBIO | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | AZTA | BIO.B | PSNL | WAT | TBIO | ILU | ||
| Latest Fiscal Year | Sep-24 | Dec-24 | Dec-24 | Dec-24 | Dec-23 | Dec-24 | ||
| LTM Period | Mar-25 | Mar-25 | Mar-25 | Mar-25 | Sep-24 | Mar-25 | ||
| Revenues | ||||||||
| Latest Twelve Months | 669 | 2,541 | 86 | 2,983 | 17 | 4,337 | ||
| Fiscal Year | 656 | 2,567 | 85 | 2,958 | 28 | 4,372 | ||
| Fiscal Year - 1 | 665 | 2,671 | 73 | 2,956 | 27 | 4,504 | ||
| Fiscal Year - 2 | 555 | 2,802 | 65 | 2,972 | 11 | 4,584 | ||
| Fiscal Year - 3 | 514 | 2,923 | 85 | 2,786 | 7 | 4,526 | ||
| Fiscal Year - 4 | 389 | 2,546 | 79 | 2,365 | 6 | 3,239 | ||
| Fiscal Year - 5 | 334 | 2,312 | 65 | 2,407 | NA | 3,543 | ||
| Net Income | ||||||||
| Latest Twelve Months | (168) | (2,164) | (84) | 657 | (47) | (966) | ||
| Fiscal Year | (164) | (1,844) | (81) | 638 | (49) | (1,223) | ||
| Fiscal Year - 1 | (13) | (637) | (108) | 642 | (48) | (1,161) | ||
| Fiscal Year - 2 | (11) | (3,628) | (113) | 708 | (39) | (4,404) | ||
| Fiscal Year - 3 | (29) | 4,254 | (65) | 693 | (18) | 762 | ||
| Fiscal Year - 4 | (26) | 3,814 | (41) | 522 | (10) | 656 | ||
| Fiscal Year - 5 | (61) | 1,759 | (25) | 592 | NA | 1,002 | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 2,563 | 12,610 | 195 | 4,509 | 105 | 10,040 | ||
| Latest Fiscal Quarter | 2,042 | 9,527 | 273 | 4,592 | 25 | 6,182 | ||
| Fiscal Year | 2,100 | 9,364 | 270 | 4,554 | 70 | 6,303 | ||
| Fiscal Year - 1 | 2,886 | 12,299 | 225 | 4,627 | 81 | 10,111 | ||
| Fiscal Year - 2 | 3,716 | 13,502 | 293 | 3,281 | 116 | 12,252 | ||
| Fiscal Year - 3 | 1,820 | 17,799 | 397 | 3,095 | 27 | 15,217 | ||
| Fiscal Year - 4 | 1,559 | 12,973 | 245 | 2,840 | 39 | 7,585 | ||
| Fiscal Year - 5 | 1,516 | 8,009 | 157 | 2,557 | NA | 7,316 | ||
| Fiscal Year - 6 | 1,095 | 5,611 | 42 | 3,727 | NA | 6,959 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 2,223 | 9,051 | 121 | 1,257 | 18 | 5,734 | ||
| Latest Fiscal Quarter | 1,701 | 6,679 | 207 | 1,962 | (27) | 2,368 | ||
| Fiscal Year | 1,769 | 6,569 | 203 | 1,829 | 0 | 2,373 | ||
| Fiscal Year - 1 | 2,535 | 8,741 | 129 | 1,150 | 47 | 5,745 | ||
| Fiscal Year - 2 | 3,363 | 9,615 | 218 | 504 | 91 | 6,599 | ||
| Fiscal Year - 3 | 1,325 | 13,685 | 310 | 368 | (25) | 10,740 | ||
| Fiscal Year - 4 | 1,214 | 9,880 | 195 | 232 | (8) | 4,694 | ||
| Fiscal Year - 5 | 1,139 | 5,755 | 107 | (216) | NA | 4,613 | ||
| Fiscal Year - 6 | 718 | 4,020 | (106) | 1,567 | NA | 3,758 | ||